TABLE 1.

Patient demographics and staging information

	Patient	Site	Pathology	EBUS-sampled stations	Stations sampled n	EBUS positive	EBUS negative	Discrepant sites#
Upstaged	1	RLL	Adenocarcinoma	7, 4R	2	7, 4R	None	4R
	2	RUL	NSCLC	Pre-carinal, 7, 2R	3	Pre-carinal	7, 2R	4R
	3	Left hilum	Squamous	7, LLL, 4L	3	7, LLL	4L	7
	4	RUL	Adenocarcinoma	4R, 7, 11R	3	7, 11R	4R	7
Downstaged	5	RLL	Squamous	4R, 7	2	7	4R	2R, 4R
	6	RLL	Squamous	4L, 2R, 4R, 2L, 7, 11R	6	7, 11R	4L, 2R, 4R, 2L	2L, 4L, 2R, 4R
	7	RLL	NSCLC	4R, 4L, 11R, 7	4	11R, 7 (atypia)	4R, 4L	4R, 4L
	8	RLL	NSCLC	4R, 4L	2	4R, 4L	None	2R
	9	RUL	Squamous	4R, 7, 10R	3	7, 10R	4R	2R, 4R
	10	RUL	NSCLC	2R, pre-carinal, 4R, right hilum	4	Pre-carinal	2R, 4R, right hilum	2R

EBUS: endobronchial ultrasound; RLL: right lower lobe; RUL: right upper lobe; NSCLC: non-small cell lung cancer. ^#: between positron emission tomography-computed tomography and EBUS-guided transbronchial needle aspiration.